CONGRESS FOR VOTERS

Michael McCaul (R-TX)

Mikaela Naylon Give Kids a Chance Act

H.R. 1262 · House bill Health

A Republican bill with 180 Democratic cosponsors · See all 313 cosponsors

Last activity — Received in the Senate.

Passed one chamber, waiting for the other to take it up

Passed one chamber, and the other has not yet sent it to a committee or put it on its calendar.

The other chamber will hand it to a committee, place it on its calendar, or leave it where it is. Nothing has been decided, and a bill can sit here indefinitely.

Its path through Congress

  1. Introduced
  2. Passed House voice vote
  3. Awaiting Senate

The House by voice vote (members called out yes or no together): no member's position on it was recorded.

What this bill would do

This Act, known as the "Mikaela Naylon Give Kids a Chance Act," amends the Federal Food, Drug, and Cosmetic Act regarding several medical and regulatory areas. It focuses heavily on expanding research and authorities for molecularly targeted pediatric cancer drugs. The legislation also extends priority review vouchers for rare pediatric diseases and adjusts orphan drug exclusivity rules. Additionally, it modifies the Organ Procurement and Transplantation Network and establishes the Abraham Accords Office within the FDA. Finally, it addresses generic drug application transparency and increases funding for the Medicare Improvement Fund.

Yes· 3 of 8

  • Scored +9

    Would children be better off under this?

    The bill focuses heavily on pediatric cancer research and rare pediatric diseases.

  • Scored +8

    Does this put more money into medical research?

    The bill provides significant funding and expanded authority for pediatric cancer research.

  • Scored +7

    Does this put more money into Medicare, the health coverage for people over 65?

    The bill significantly increases the funding for the Medicare Improvement Fund.

The opposite

No question was scored the opposite.